Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 20, Issue 1, 2010, Pages 25-32

  Chang, Kiki D ^a   Saxena, Kirti ^a   Howe, Meghan ^a   Simeonova, Diana ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CENTRAL STIMULANT AGENT; LITHIUM; MOOD STABILIZER; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADOLESCENT; ARTICLE; BIPOLAR DISORDER; CHILD; DRUG EFFECT; DRUG EXPOSURE; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; NEUROPROTECTION; ONSET AGE; PROGENY; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; AGE OF ONSET; BIPOLAR DISORDER; CALIFORNIA; CHILD; CHILD OF IMPAIRED PARENTS; COHORT STUDIES; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PARENT-CHILD RELATIONS; PARENTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77249143009     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2009.0036     Document Type: Article

References (61)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders-Text Revision (DSM-IV-TR). Washington (DC): American Psychiatric Association, 2000.
2. Andreasen NC, Endicott J, Spitzer RL, Winokur G: The family history method using diagnostic criteria. Reliability and validity. Arch Gen Psychiatry 34:1229-1235, 1977.
3. Baumer FM, Howe M, Gallelli K, Simeonova DI, Hallmayer J, Chang KD: A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene. Biol Psychiatry 60:1005-1012, 2006.
4. Bhangoo RK, Lowe CH, Myers FS, Treland J, Curran J, Towbin KE, Leibenluft E: Medication use in children and adolescents treated in the community for bipolar disorder. J Child Adolesc Psychopharmacol 13:515-522, 2003.
5. Biederman J, Mick E, Spencer TJ, Wilens TE, Faraone SV: Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 10:185-192, 2000.
6. Braaten EB, Biederman J, DiMauro A, Mick E, Monuteaux MC, Muehl K, Faraone SV: Methodological complexities in the diagnosis of major depression in youth: An analysis of mother and youth self-reports. J Child Adolesc Psychopharmacol 11:395-407, 2001.
7. Carlson GA, Kelly KL: Stimulant rebound: How common is it and what does it mean? J Child Adolesc Psychopharmacol 13:137-142, 2003.
8. Carlson GA, Mick E: Drug-induced disinhibition in psychiatrically hospitalized children. J Child Adolesc Psychopharmacol 13:153-163, 2003.
9. Carlson GA, Loney J, Salisbury H, Kramer JR, Arthur C: Stimulant treatment in young boys with symptoms suggesting childhood mania: A report from a longitudinal study. J Child Adolesc Psychopharmacol 10:175-184, 2000a.
10. Carlson GA, Loney J, Salisbury H, Kramer JR, Arthur C: Stimulant treatment in young boys with symptoms suggesting childhood mania: A report from a longitudinal study. J Child Adolesc Psychopharmacol 10:175-184, 2000b.
11. Carter TD, Mundo E, Parikh SV, Kennedy JL: Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 37:297-303, 2003.
12. Chang KD, Steiner H: Offspring studies in child and early adolescent bipolar disorder. In: Bipolar Disorder in Childhood and Early Adolescence. Edited by Geller B, DelBello M. New York: The Guilford Press, 2003, pp 107-129.
13. Chang KD, Steiner H, Ketter TA: Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry 39:453-460, 2000.
14. Chang KD, Dienes K, Blasey C, Adleman N, Ketter T, Steiner H: Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J Clin Psychiatry 64:936-942, 2003b.
15. Chang K, Howe M, Gallelli K, Miklowitz D: Prevention of pediatric bipolar disorder: Integration of neurobiological and psychosocial processes. Ann NY Acad Sci 1094:235-247, 2006.
16. Chang K, Karchemskiy A, Barnea-Goraly N, Garrett A, Simeonova DI, Reiss A: Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:565-573, 2005.
17. Chang K, Steiner H, Dienes K, Adleman N, Ketter T: Bipolar offspring: A window into bipolar disorder evolution. Biol Psychiatry 53:945-951, 2003a.
18. Cicero D, El-Mallakh RS, Holman J, Robertson J: Antidepressant exposure in bipolar children. Psychiatry 66:317-322, 2003.
19. Craney J, Geller B: Clinical implications of antidepressant and stimulant use on switching from depression to mania in children. J Child Adolesc Psychopharmacol 13:201-204, 2003.
20. DelBello MP, Geller B: Review of studies of child and adolescent offspring of bipolar parents. Bipolar Disord 3:325-334, 2001.
21. DelBello MP, Adler CM, Whitsel RM, Stanford KE, Strakowski SM: A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder. J Clin Psychiatry 68:789-795, 2007.
22. DelBello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM: Prior stimulant treatment in adolescents with bipolar disorder: Association with age at onset. Bipolar Disord 3: 53-57, 2001.
23. Diler RS, Avci A: SSRI-induced mania in obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 38:6-7, 1999.
24. Faedda GL, Baldessarini RJ, Glovinsky IP, Austin NB: Treatmentemergent mania in pediatric bipolar disorder: A retrospective case review. J Affect Disord 82:149-158, 2004.
25. Faraone SV, Biederman J, Wozniak J, Mundy E, Mennin D, O'Donnell D: Is comorbidity with ADHD a marker for juvenile-onset mania? J Am Acad Child Adolesc Psychiatry 36:1046-1055, 1997.
26. Findling RL, Frazier TW, Youngstrom EA, McNamara NK, Stansbrey RJ, Gracious BL, Reed MD, Demeter CA, Calabrese JR: Doubleblind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. J Clin Psychiatry 68:781-788, 2007.
27. First MB, Spitzer RL, Gibbon M and Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, version 2.0). New York: Biometric Research, New York State Psychiatric Institute, 1995.
28. Foland LC, Altshuler LL, Sugar CA, Lee AD, Leow AD, Townsend J, Narr KL, Asuncion DM, Toga AW, Thompson PM: Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. Neuroreport 19:221-224, 2008.
29. Galanter CA, Carlson GA, Jensen PS, Greenhill LL, Davies M, Li W, Chuang SZ, Elliott GR, Arnold LE, March JS, Hechtman L, Pelham WE, Swanson JM: Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol 13:123-136, 2003.
30. Geller B, Cooper TB, Zimerman B, Frazier J, Williams M, Heath J, Warner K: Lithium for prepubertal depressed children with family history predictors of future bipolarity: A double-blind, placebo-controlled study. J Affect Disord 51:165-175, 1998.
31. Geller BG, Williams M, Zimerman B, Frazier J: WASH-U-KSADS (Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia). St. Louis (Missouri): Washington University, 1996.
32. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM: Antidepressants for bipolar depression: A systematic review of randomized, controlled trials. Am J Psychiatry 161:1537-1547, 2004.
33. Go FS, Malley EE, Birmaher B, Rosenberg DR: Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 8:73-80, 1998.
34. Goldberg JF, Truman CJ: Antidepressant-induced mania: An overview of current controversies. Bipolar Disord 5:407-420, 2003.
35. Guile JM: Sertraline-induced behavioral activation during the treatment of an adolescent with major depression. J Child Adolesc Psychopharmacol 6:281-285, 1996.
36. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M: Antidepressantinduced mania in bipolar patients: Identification of risk factors. J Clin Psychiatry 62:249-255, 2001.
37. Hillegers MH, Burger H, Wals M, Reichart CG, Verhulst FC, Nolen WA, Ormel J: Impact of stressful life events, familial loading and their interaction on the onset of mood disorders: Study in a highrisk cohort of adolescent offspring of parents with bipolar disorder. Br J Psychiatry 185:97-101, 2004.
38. Howland RH: Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol 16:425-427, 1996.
39. Jerome L: Hypomania with fluoxetine. J Am Acad Child Adolesc Psychiatry 30:850-851, 1991.
40. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Versions (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988.
41. Koehler-Troy C, Strober M, Malenbaum R: Methylphenidate-induced mania in a prepubertal child. J Clin Psychiatry 47:566-567, 1986.
42. Koszewska I, Rybakowski JK: Antidepressant-induced mood conversions in bipolar disorder: A retrospective study of tricyclic versus non-tricyclic antidepressant drugs. Neuropsychobiology 59:12-16, 2009.
43. Manji HK, Moore GJ, Chen G: Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: Implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 48:740-754, 2000.
44. Martin A, Young C, Leckman JF, Mukonoweshuro C, Rosenheck R, Leslie D: Age effects on antidepressant-induced manic conversion. Arch Pediatr Adolesc Med 158:773-780, 2004.
45. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK, Menji HK: Lithium-induced increase in human brain grey matter. Lancet 356:1241-1242, 2000.
46. Post RM: Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149:999-1010, 1992.
47. Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE Jr, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA: Rate of switch in bipolar patients prospectively treated with secondgeneration antidepressants as augmentation to mood stabilizers. Bipolar Disord 3:259-265, 2001.
48. Poznanski EO, Mokros HB. Children's Depression Rating Scale, Revised (CDRS-R) Manual. Los Angeles (California): Western Psychological Services, 1995.
49. Reichart CG, Nolen WA: Earlier onset of bipolar disorder in children by antidepressants or stimulants? An hypothesis. J Affect Disord 78:81-84, 2004.
50. Ryan ND: Treatment of depression in children and adolescents. Lancet 366:933-940, 2005.
51. Scheffer RE, Kowatch RA, Carmody T, Rush AJ: Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 162:58-64, 2005.
52. Soutullo CA, Chang KD, Diez-Suarez A, Figueroa-Quintana A, Escamilla-Canales I, Rapado-Castro M, Ortuno F: Bipolar disorder in children and adolescents: International perspective on epidemiology and phenomenology. Bipolar Disord 7:497-506, 2005.
53. Soutullo CA, DelBello MP, Ochsner JE, McElroy SL, Taylor SA, Strakowski SM, Keck PE Jr: Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J Affect Disord 70:323-327, 2002.
54. Tillman R, Geller B: Controlled study of switching from attention-deficit/hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6-year prospective follow-up: Rate, risk, and predictors. Dev Psychopathol 18:1037-1053, 2006.
55. Tillman R, Geller B, Bolhofner K, Craney JL, Williams M, Zimerman B: Ages of onset and rates of syndromal and subsyndromal comorbid DSM-IV diagnoses in a prepubertal and early adolescent bipolar disorder phenotype. J Am Acad Child Adolesc Psychiatry 42:1486-1493, 2003.
56. Vitiello B: Long-term effects of stimulant medications on the brain: Possible relevance to the treatment of attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 11:25-34, 2001.
57. Wehr TA, Goodwin FK: Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 144:1403-1411, 1987.
58. Wilens TE, Biederman J, Kwon A, Chase R, Greenberg L, Mick E, Spencer TJ: A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol 13:143-152, 2003.
59. Wong IC, Besag FM, Santosh PJ, Murray ML: Use of selective serotonin reuptake inhibitors in children and adolescents. Drug Safety 27:991-1000, 2004.
60. Young RC, Biggs JT, Ziegler V, Meyer DA: A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133:429-435, 1978.
61. Youngstrom EA, Findling RL, Calabrese JR: Effects of adolescent manic symptoms on agreement between youth, parent, and teacher ratings of behavior problems. J Affect Disord 82(Suppl 1):S5-S16, 2004.